chr1-241519719-A-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_000143.4(FH):āc.4T>Cā(p.Tyr2His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000538 in 1,543,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000143.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FH | NM_000143.4 | c.4T>C | p.Tyr2His | missense_variant | 1/10 | ENST00000366560.4 | NP_000134.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FH | ENST00000366560.4 | c.4T>C | p.Tyr2His | missense_variant | 1/10 | 1 | NM_000143.4 | ENSP00000355518 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000273 AC: 4AN: 146302Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 78260
GnomAD4 exome AF: 0.0000338 AC: 47AN: 1391056Hom.: 0 Cov.: 31 AF XY: 0.0000321 AC XY: 22AN XY: 685234
GnomAD4 genome AF: 0.000236 AC: 36AN: 152332Hom.: 0 Cov.: 33 AF XY: 0.000268 AC XY: 20AN XY: 74512
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Observed in individuals with pheochromocytoma, paraganglioma, kidney cancer, or colon cancer (PMID: 29684080, 30877234); This variant is associated with the following publications: (PMID: 30877234, 29684080, 37529773) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
Hereditary cancer-predisposing syndrome Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Jun 24, 2021 | - - |
Fumarase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 04, 2024 | - - |
FH-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 30, 2023 | The FH c.4T>C variant is predicted to result in the amino acid substitution p.Tyr2His. This variant has been reported in one individual with pheochromocytoma as a germline variant of unknown significance (Supplementary Table S3 in Ben Aim et al. 2019. PubMed ID: 30877234). This variant is reported in 0.070% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-241683019-A-G). It has conflicting interpretations of likely benign and uncertain significance in ClinVar (https://preview.ncbi.nlm.nih.gov/clinvar/variation/460359/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at